• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 424B3 filed by DIH Holdings US Inc.

    3/10/25 4:40:35 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care
    Get the next $DHAI alert in real time by email
    424B3 1 form424b3.htm

     

    Prospectus Supplement No. 4

     

    Filed pursuant to Rule 424(b)(3)

    Registration No. 333-283853

     

    DIH HOLDING US, INC.

     

    Dated March 10, 2025

     

    To the Prospectus dated January 31, 2025

     

    This Prospectus Supplement No. 4 updates, amends and supplements the prospectus dated January 31 2025, as amended and supplemented by Prospectus Supplement No. 1 dated February 14, 2025, Prospectus Supplement No. 2 dated February 18, 2025, and Prospectus Supplement No. 3, dated March 3, 2025 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-283853).

     

    This Prospectus Supplement No. 4 is being filed to update, amend, and supplement the information included in the Prospectus with the information contained in our Current Report on Form 8-K, filed with the United States Securities and Exchange Commission on March 7, 2025, which is set forth below.

     

    This Prospectus Supplement No. 4 is not complete without the Prospectus. This Prospectus Supplement No. 4 should be read in conjunction with the Prospectus, which is to be delivered with this Prospectus Supplement No. 4, and is qualified by reference thereto, except to the extent that the information in this Prospectus Supplement No. 4 updates or supersedes the information contained in the Prospectus. Please keep this Prospectus Supplement No. 4 with your Prospectus for future reference.

     

    Our Common Stock and Warrants are traded on The Nasdaq Stock Market LLC under the symbols “DHAI.” and “DHAIW”, respectively. On March 7, 2025, the last reported sale price of our Common Stock was $0.3930 per share.

     

    INVESTING IN OUR SECURITIES INVOLVES RISKS. YOU SHOULD CAREFULLY CONSIDER THE “RISK FACTORS” INCLUDED IN OUR ANNUAL REPORT ON FORM 10-K, as amended by Form 10-K/A, FOR THE YEAR ENDED MARCH 31, 2024 AS WELL AS SUBSEQUENTLY FILED FORM 10-QS BEFORE YOU DECIDE TO INVEST.

     

    Neither the Securities and Exchange Commission (the “SEC”) nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

     

    THE INFORMATION IN THIS PROSPECTUS SUPPLEMENT NO. 4 IS NOT COMPLETE AND MAY CHANGE. THIS PROSPECTUS SUPPLEMENT NO. 4 IS NOT AN OFFER TO SELL THESE SECURITIES AND IT IS NOT SOLICITING AN OFFER TO BUY THESE SECURITIES IN ANY STATE WHERE THE OFFER OR SALE IS NOT PERMITTED.

     

    The date of this Prospectus Supplement No. 4 is March 10, 2025

     

     

     

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

     

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): March 5, 2025

     

    DIH HOLDING US, INC.

    (Exact name of Registrant as Specified in Its Charter)

     

    Delaware   001-41250   98-1624542

    (State or Other Jurisdiction

    of Incorporation)

     

    (Commission

    File Number)

     

    (IRS Employer

    Identification No.)

     

    77 Accord Park Drive; Suite D-1    
    Norwell, Massachusetts   02061
    (Address of Principal Executive Offices)   (Zip Code)

     

    Registrant’s Telephone Number, Including Area Code: 877 944-2200

     

    Not Applicable

    (Former Name or Former Address, if Changed Since Last Report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

      ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
         
      ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
         
      ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
         
      ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    Class A Common Stock   DHAI   The Nasdaq Stock Market LLC
    Warrants   DHAIW   The Nasdaq Stock Market LLC

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

     

    Emerging growth company ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     

     

     

    Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

     

    On March 5, 2025, DIH Holding US, Inc. (the “Company”), received a letter (the “MVLS Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that for the last 30 consecutive business days prior to the date of the MVLS Notice, the Company’s Minimum Value of Listed Securities (“MVLS”) was less than $50.0 million, which does not meet the requirement for continued listing on The Nasdaq Global Market, as required by Nasdaq Listing Rule 5450(b)(2)(A)) (the “MVLS Rule”). In accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Staff has provided the Company with 180 calendar days, or until September 1, 2025, to regain compliance with the MVLS Rule. The MVLS Notice has no immediate effect on the listing of the Company’s securities on The Nasdaq Global Market.

     

    If the Company regains compliance with the MVLS Rule, the Staff will provide written confirmation to the Company and close the matter. To regain compliance with the MVLS Rule, the Company’s MVLS must meet or exceed $50.0 million for a minimum of ten consecutive business days during the 180-day compliance period ending on September 1, 2025. In the event the Company does not regain compliance with the MVLS Rule prior to the expiration of the compliance period, it will receive written notification that its securities are subject to delisting. At that time, the Company may appeal the delisting determination to a Hearings Panel.

     

    The Company will continue to monitor its MVLS and consider its available options to regain compliance with the MVLS Rule. However, there can be no assurance that the Company will be able to regain compliance with the MVLS Rule.

     

    Item 9.01 Financial Statements and Exhibits.

     

    104   Cover Page Interactive Data File (Formatted in Inline XBRL)

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    DIH HOLDING US, INC.
         
    Date: March 7, 2025 By: /s/ Jason Chen
       

    Jason Chen

    Chief Executive Officer and Chairman

     

     

    Get the next $DHAI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DHAI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $DHAI
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • DIH Announces Third Quarter 2025 Financial Results

      NORWELL, Mass., Feb. 14, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in physical rehabilitation, which incorporates visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced financial results for the third fiscal quarter ended December 31, 2024. Recent Highlights Revenue of $15.1 million for the quarter ended December 31, 2024, representing a decline of 21% over the prior year periodDevice revenue of $11.7 million and service reven

      2/14/25 5:07:01 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • DIH Expands Strategic Partnership with Zahrawi Group

      NORWELL, Mass. and DUBAI, United Arab Emirates, Feb. 04, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the expansion of their strategic partnership with Zahrawi Group (MTC Company), DIH's representative and sales partner, to include Saudi Arabia.  Building on a successful collaboration that started in 2019, the partnership now spans four countries: th

      2/4/25 8:00:00 AM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • DIH Announces Closing of $4.6 Million Public Offering

      NORWELL, Mass., Feb. 03, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH" or the "Company") (NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the closing of its previously announced public offering of an aggregate of 5,937,100 units at a public offering price of $0.7832 per unit. Each unit consists of one share of Class A common stock and one Class A warrant to purchase one share of Class A common stock

      2/3/25 4:05:00 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care

    $DHAI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Baucus Max was granted 52,817 shares (SEC Form 4)

      4 - DIH HOLDING US, INC. (0001883788) (Issuer)

      12/9/24 4:03:26 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • Director Chen Cathryn was granted 105,634 shares and acquired 4,885,173 shares (SEC Form 4)

      4 - DIH HOLDING US, INC. (0001883788) (Issuer)

      12/9/24 4:03:23 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • Director Eberts F Samuel Iii was granted 105,634 shares (SEC Form 4)

      4 - DIH HOLDING US, INC. (0001883788) (Issuer)

      12/9/24 4:03:23 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care

    $DHAI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by DIH Holdings US Inc.

      SC 13G/A - DIH HOLDING US, INC. (0001883788) (Subject)

      11/14/24 6:07:49 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • Amendment: SEC Form SC 13G/A filed by DIH Holdings US Inc.

      SC 13G/A - DIH HOLDING US, INC. (0001883788) (Subject)

      11/14/24 12:46:18 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13D filed by DIH Holdings US Inc.

      SC 13D - DIH HOLDING US, INC. (0001883788) (Subject)

      2/20/24 5:18:47 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care

    $DHAI
    SEC Filings

    See more
    • SEC Form 424B3 filed by DIH Holdings US Inc.

      424B3 - DIH HOLDING US, INC. (0001883788) (Filer)

      5/5/25 4:35:42 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • SEC Form 424B3 filed by DIH Holdings US Inc.

      424B3 - DIH HOLDING US, INC. (0001883788) (Filer)

      5/5/25 4:30:39 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • DIH Holdings US Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

      8-K - DIH HOLDING US, INC. (0001883788) (Filer)

      5/2/25 4:30:14 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care

    $DHAI
    Leadership Updates

    Live Leadership Updates

    See more
    • DIH Appoints Shepherd Center as a DIH Center of Excellence

      NORWELL, Mass. and ATLANTA, Dec. 23, 2024 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the appointment of Shepherd Center as DIH Center of Excellence. Through this partnership, DIH and Shepherd Center aim to further enhance rehabilitation outcomes and drive advancements in rehabilitation, creating new opportunities for patient recovery. The DIH Center of

      12/23/24 7:00:00 AM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • DIH Appoints Sheltering Arms Institute as a DIH Center of Excellence

      NORWELL, Mass. and RICHMOND, Va., Dec. 16, 2024 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the designation of Sheltering Arms Institute, a collaboration with VCU Health, as DIH Center of Excellence. By partnering with Sheltering Arms Institute, DIH continues to build a strong presence among top-tier healthcare providers dedicated to enhancing patient re

      12/16/24 4:05:00 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • DIH Appoints Dietmar Dold as Chief Operating Officer

      NORWELL, Mass., Nov. 04, 2024 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a leading global robotics and virtual reality ("VR") technology provider in the rehabilitation and human performance industry, today announced the appointment of Mr. Dietmar Dold as Chief Operating Officer, effective immediately.  Mr. Dold brings to DIH over 25 years of operating experience across multiple industries, and has demonstrated significant expertise in driving innovative transformation on a global scale. In his role as Chief Operating Officer, Mr. Dold will define and lead DIH's multi-group operating strategy, where he is expected to optimize manufacturing and sourcing initiatives, buil

      11/4/24 8:17:00 AM ET
      $DHAI
      Medical/Dental Instruments
      Health Care